Cover Image

Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections

Increasing evidence suggests that dalbavancin is an effective long-term treatment for ventricular assist device (VAD) infections, with various prolonged dosing regimens currently in use. This retrospective study aimed to assess dalbavancin pharmacokinetics in VAD patients and identify optimal, feasi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ute Chiriac (Author), Uwe Liebchen (Author), Otto Roman Frey (Author), Heike Lanzinger (Author), Sabrina Klein (Author), Torsten Hoppe-Tichy (Author), Matthias Karck (Author), Anna Meyer (Author), Benedict Morath (Author)
Format:	Book
Published:	MDPI AG, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Dalbavancin
by: Ute Chiriac, et al.
Published: (2022)

Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
by: Jessica J. Tuan, et al.
Published: (2022)

Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
by: Ute Chiriac, et al.
Published: (2023)

Cefiderocol Protects against Cytokine- and Endotoxin-Induced Disruption of Vascular Endothelial Cell Integrity in an In Vitro Experimental Model
by: Dagmar Hildebrand, et al.
Published: (2022)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
by: Elisa Molinelli, et al.
Published: (2022)

Dalbavancin in the treatment of skin and soft tissues infection
by: Ana Candela Fajardo, et al.
Published: (2017)

Evaluating the Use of Dalbavancin for Off-Label Indications
by: Katherine Taylor, et al.
Published: (2022)

Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin - A real-world data and retrospective cost analysis
by: Christoph T. Baltin, et al.
Published: (2023)

Dalbavancin in Bone and Joint Infections: A Systematic Review
by: Sofia Lovatti, et al.
Published: (2023)

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
by: Luis Buzón-Martín, et al.
Published: (2021)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
by: Leama Ajaka, et al.
Published: (2020)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
by: Simonetti O, et al.
Published: (2021)

Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs
by: Gatti M, et al.
Published: (2021)

A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections
by: Dimitra Dimopoulou, et al.
Published: (2023)

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
by: Andrés Ruiz-Sancho, et al.
Published: (2023)

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
by: Jason W Bennett, et al.
Published: (2008)

Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience
by: Dario Cattaneo, et al.
Published: (2023)

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
by: Leuthner KD, et al.
Published: (2016)

Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections
by: Giacomo Stroffolini, et al.
Published: (2022)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
by: Connor Evins, et al.
Published: (2022)

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center
by: Lucia Brescini, et al.
Published: (2021)

In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement
by: Mar Sánchez-Somolinos, et al.
Published: (2023)

Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
by: Altea Gallerani, et al.
Published: (2023)

Dalbavancin versus standard of care for the treatment of osteomyelitis in adults: A retrospective matched cohort study
by: Thamer A. Almangour, et al.
Published: (2020)

Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience
by: Sara Maria Scarano, et al.
Published: (2024)

Determination of a Tentative Epidemiological Cut-Off Value (ECOFF) for Dalbavancin and <i>Enterococcus faecium</i>
by: Robert E. Weber, et al.
Published: (2021)

In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) <i>Staphylococcus aureus</i> Isolates
by: Dafne Bongiorno, et al.
Published: (2020)

A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice
by: Frank Hanses, et al.
Published: (2022)

New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
by: Juul JJ, et al.
Published: (2016)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
by: Carmen Hidalgo-Tenorio, et al.
Published: (2019)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
by: Pedro Luis Gonzalez, et al.
Published: (2018)

TNF-Like Weak Inducer of Apoptosis Aggravates Left Ventricular Dysfunction after Myocardial Infarction in Mice
by: Kai-Uwe Jarr, et al.
Published: (2014)

Quality management: reduction of waiting time and efficiency enhancement in an ENT-university outpatients' department
by: Helbig Matthias, et al.
Published: (2009)

Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality
by: Mar de Pablo-Miró, et al.
Published: (2021)

Real-World Use of Dalbavancin for Treatment of Soft Tissue and Bone Infection in Children: Safe, Effective and Hospital-Time Sparing
by: Désirée Caselli, et al.
Published: (2024)

Qualitätsleitfaden Offshore-Kampfmittelbeseitigung
by: Frey, Torsten
Published: (2019)

Qualitätsleitfaden Offshore-Kampfmittelbeseitigung
by: Frey, Torsten
Published: (2019)

Qualitätsleitfaden Offshore-Kampfmittelbeseitigung
by: Frey, Torsten
Published: (2019)

Real-World Data Regarding Dalbavancin Use before and during the COVID-19 Pandemic-A Single-Center Retrospective Study
by: Petros Ioannou, et al.
Published: (2023)

Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring
by: Pier Giorgio Cojutti, et al.
Published: (2022)